You have reached the TARGAXAN® (rifaximin-α) website which is intended for UK healthcare professionals and has been developed by Norgine to provide you with information about the product.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (United Kingdom) or www.hpra.ie (Ireland)
Adverse events should also be reported to Medical Information at Norgine Pharmaceuticals Ltd on 01895 826606 or Email: medinfo@norgine.com
Product under licence from Alfasigma S.p.A. TARGAXAN is a registered trademark of the Alfasigma group of companies, licensed to the Norgine group of companies
NORGINE and the sail logo are registered trademarks of the Norgine group of companies
Date of preparation: May 2020 Job Code: UKE-HEP-XIF-2000012 © 2019 Norgine
Privacy Policy
Adverse events should also be reported to Medical Information at Norgine Pharmaceuticals Ltd on 01895 826606 or Email: medinfo@norgine.com
Product under licence from Alfasigma S.p.A. TARGAXAN is a registered trademark of the Alfasigma group of companies, licensed to the Norgine group of companies
NORGINE and the sail logo are registered trademarks of the Norgine group of companies
Date of preparation: May 2020 Job Code: UKE-HEP-XIF-2000012 © 2019 Norgine
Privacy Policy